Prostate drugs treble heart death risk for some patients

29 Oct 2014


The other prostate cancer story of the day comes from Harvard University which claims that androgen deprivation therapy used to treat prostate cancer could treble the risk of heart death among patients with a history of cardiac problems. The Telegraph


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story